Clinical Trial

Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema

Name: Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema — clinical trial record (NCT07489131)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ALVOEYE-HD

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea HD in Participants with Diabetic Macular Edema.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-01

Trial Details

NCT Number	NCT07489131
Lead Sponsor	Alvotech Swiss AG
Conditions	Diabetic Macular Edema
Enrollment	256 participants
Start Date	2026-04-22
Primary Completion	2027-07 (estimated)
Study Completion	2028-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-30